2-in-1 COVID-flu vaccine looks promising in trial — but experts say approval may be delayed Late-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect the shot's approval..."> 2-in-1 COVID-flu vaccine looks promising in trial — but experts say approval may be delayed Late-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect the shot's approval..." /> 2-in-1 COVID-flu vaccine looks promising in trial — but experts say approval may be delayed Late-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect the shot's approval..." />

Blogs

Discover Blogs

Marketplace

Discover Marketplace

Groepen

Discover Groepen My Groups

Pagina

Discover Pagina hield van pagina 's

Meer

Popular Posts Discover Posts
Marketplace Blogs Pagina Groepen
TOON ALLES

Upgrade to Pro
LiveScience een koppeling hebt gedeeld
2025-05-19 19:57:03 ·
2-in-1 COVID-flu vaccine looks promising in trial — but experts say approval may be delayed

Late-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect the shot's approval may be delayed.
#2in1 #covidflu #vaccine #looks #promising
2-in-1 COVID-flu vaccine looks promising in trial — but experts say approval may be delayed
Late-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect the shot's approval may be delayed. #2in1 #covidflu #vaccine #looks #promising
WWW.LIVESCIENCE.COM
2-in-1 COVID-flu vaccine looks promising in trial — but experts say approval may be delayed
Late-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect the shot's approval may be delayed.
·102 Views
Please log in to like, share and comment!